An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.
Several professionals stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.
Platform Reaction and Material Removal
According to the social media company, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in enhancing compliance measures.
Online Marketplace Operations
Research also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.
Within minutes of joining one community, a vendor shared contact information, where most transactions take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Details and Pricing
Within these communities, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram stated it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.
Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious medical dangers”.
